EPS for Calithera Biosciences (CALA) Expected At $-0.29, Noah Holdings Limited (NOAH) Shorts Down By 2.1%

July 25, 2017 - By Hazel Jackson

Analysts expect Calithera Biosciences Inc (NASDAQ:CALA) to report $-0.29 EPS on August, 8.They anticipate $0.26 EPS change or 47.27% from last quarter’s $-0.55 EPS. After having $-0.22 EPS previously, Calithera Biosciences Inc’s analysts see 31.82% EPS growth. About 163,262 shares traded. Calithera Biosciences Inc (NASDAQ:CALA) has risen 278.82% since July 25, 2016 and is uptrending. It has outperformed by 262.12% the S&P500.

Noah Holdings Limited (NYSE:NOAH) had a decrease of 2.1% in short interest. NOAH’s SI was 3.58M shares in July as released by FINRA. Its down 2.1% from 3.66M shares previously. With 182,300 avg volume, 20 days are for Noah Holdings Limited (NYSE:NOAH)’s short sellers to cover NOAH’s short positions. The SI to Noah Holdings Limited’s float is 15.07%. About 17,106 shares traded. Noah Holdings Limited (ADR) (NYSE:NOAH) has risen 17.05% since July 25, 2016 and is uptrending. It has outperformed by 0.35% the S&P500.

Noah Holdings Limited is a wealth management service well-known provider with a focus on global wealth investment and asset allocation services for high net worth individuals and enterprises in China. The company has market cap of $1.87 billion. The Firm operates through three divisions: wealth management, asset management and Internet finance. It has a 20.92 P/E ratio. It also provides Internet finance services to clients in China.

Investors sentiment increased to 1.2 in Q4 2016. Its up 0.44, from 0.76 in 2016Q3. It is positive, as 9 investors sold Calithera Biosciences Inc shares while 6 reduced holdings. 4 funds opened positions while 14 raised stakes. 5.98 million shares or 0.90% more from 5.92 million shares in 2016Q3 were reported. First Eagle Investment accumulated 438,103 shares or 0% of the stock. Blackrock Institutional Trust Na reported 0% in Calithera Biosciences Inc (NASDAQ:CALA). Bridgeway Management has invested 0.01% in Calithera Biosciences Inc (NASDAQ:CALA). Howland Capital Lc holds 0% of its portfolio in Calithera Biosciences Inc (NASDAQ:CALA) for 12,000 shares. Susquehanna Grp Inc Ltd Liability Partnership accumulated 0% or 74,569 shares. Tfs Ltd owns 28,408 shares. The Delaware-based Blackrock Advsrs Ltd Liability Corporation has invested 0% in Calithera Biosciences Inc (NASDAQ:CALA). Vanguard Group has invested 0% of its portfolio in Calithera Biosciences Inc (NASDAQ:CALA). Goldman Sachs Gru Incorporated reported 0% stake. California Pub Employees Retirement Sys holds 14,100 shares or 0% of its portfolio. Blackrock Fund Advsr reported 36,144 shares. Fmr Limited Company reported 0% of its portfolio in Calithera Biosciences Inc (NASDAQ:CALA). Wells Fargo Company Mn stated it has 0% of its portfolio in Calithera Biosciences Inc (NASDAQ:CALA). Franklin Street Advisors Nc stated it has 124,580 shares. Geode Cap Mngmt Limited Liability Corporation owns 66,328 shares.